Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha

Haematologica. 1999 Apr;84(4):306-11.

Abstract

Background and objective: Vascular fibrinolysis, a major natural defense mechanism against thrombosis, is a highly regulated process. The aim of this study was to evaluate the effect of endotoxin, tumor necrosis factor-alpha (TNFalpha) and interleukin-1alpha (IL-1alpha), on the fibrinolytic potential of cultured human umbilical vein endothelial cells (HUVEC).

Design and methods: Samples of stimulated conditioned media were collected over a period of 24 hours to determine: plasminogen activator (PA) and plasminogen activator inhibitor (PAI) activity, PAI-1 mRNA, tissue-type plasminogen activator (t-PA) antigen and urokinase-type plasminogen activator (u-PA) antigen.

Results: Similar changes were observed after endotoxin and cytokine stimulation: there was a significant increase of PAI activity (p<0.01), starting at 6 hours, which remained 24 hours after stimulation. PAI-1 mRNA also showed an important rise with these agents, although cytokines induced an earlier and more intense inhibitor response (up to 6-fold increase). PA activity increased significantly at 6 hours (p<0.01) to drop at 24 hours and was mainly related to the presence of u-PA.

Interpretation and conclusions: We conclude that endotoxin,+TNFalpha and IL-1alpha induce profound alterations in the fibrinolytic potential of HUVEC, characterized by an initial rise of activators (u-PA) followed by a strong increase of PAI-1. These changes may be of pathophysiologic significance for thrombosis and inflammatory reactions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Culture Media, Conditioned / analysis
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology*
  • Endotoxins / pharmacology*
  • Fibrinolysis / drug effects*
  • Humans
  • Interleukin-1 / pharmacology*
  • Plasminogen Activator Inhibitor 1 / analysis
  • Plasminogen Activators / analysis
  • Tissue Plasminogen Activator / analysis
  • Tumor Necrosis Factor-alpha / pharmacology*
  • Urokinase-Type Plasminogen Activator / analysis

Substances

  • Culture Media, Conditioned
  • Endotoxins
  • Interleukin-1
  • Plasminogen Activator Inhibitor 1
  • Tumor Necrosis Factor-alpha
  • Plasminogen Activators
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator